Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biweekly versus standard cisplatin + gemcitabine for elderly advanced biliary tract cancer (BCG65)
TCTR20251010002Phase 3Recruiting
- Sponsor
- N/A
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin, gemcitabine in biliary cancer, sponsored by N/A. Started May 2024; status: recruiting.
02
Drugs
cisplatingemcitabine
03
Conditions
biliary cancer
Beyond the preview
Go deeper on TCTR20251010002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251010002.